Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation

Ann Hematol. 2019 Mar;98(3):789-791. doi: 10.1007/s00277-019-03596-z. Epub 2019 Jan 14.

Authors

O Al-Sawaf¹, P Köhler¹, D A Eichenauer¹, B Böll¹, M Kochanek¹, A Shimabukuro-Vornhagen²

Affiliations

¹ Department I of Internal Medicine, Critical Care Medicine, University Hospital of Cologne, Cologne, Germany.
² Department I of Internal Medicine, Critical Care Medicine, University Hospital of Cologne, Cologne, Germany. [email protected].

PMID: 30643938
DOI: 10.1007/s00277-019-03596-z

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Chest Syndrome / etiology
Acute Chest Syndrome / therapy*
Anemia, Sickle Cell / blood
Anemia, Sickle Cell / complications
Anemia, Sickle Cell / drug therapy
Anemia, Sickle Cell / therapy*
Anticoagulants / administration & dosage
Anticoagulants / therapeutic use
Combined Modality Therapy
Dobutamine / therapeutic use
Extracorporeal Membrane Oxygenation / methods*
Hemorrhage / prevention & control
Humans
Hydroxyurea / therapeutic use
Male
Multiple Organ Failure / etiology
Thrombosis / prevention & control
Young Adult

Substances

Anticoagulants
Dobutamine
Hydroxyurea